Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research & production of cell-based pharmaceuticals – developed based on artificial platelet technology from ...

INCHEON, South Korea, May 26, 2026 /PRNewswire/ -- SK bioscience announced that it has signed an agreement with Colombia's state-owned pharmaceutical company VECOL for vaccine technology transfer and ...

Daré Bioscience’s DARE-LARC1 Platform Technology has Transformative Potential for Women’s Health as well as in Treating a Broad Range of Diseases Strategic Process Underway to Explore Partnering ...

CAMBRIDGE, England & TORONTO--(BUSINESS WIRE)--Shift Bioscience, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the establishment of a new North ...

New USD 130 million facility to focus on next-generation, sustainable solutions for farming Enhanced commitment to UK as a key hub for global R&D and innovation BASEL, Switzerland--(BUSINESS ...

The Nature Index tracks primary research articles from 178 applied, health, natural and social sciences journals, across many different publishers, chosen by an independent group of researchers. The ...

Offers synthetic DNA products, including genes, sample prep tools, antibody libraries, and DNA data storage solutions. Operates a platform-based business model leveraging silicon chip technology to ...

Lexaria Bioscience (LEXX) jumped 12% after a $2.6M Australian R&D tax rebate boosted cash runway without dilution.

SK bioscience collaborates with Colombia's government-led US$260 million vaccine localization initiative through technology transfer and local manufacturing cooperation with state-owned pharmaceutical ...

Syngenta, a global leader in agricultural innovation, today announced it is building a new USD 130 million (GBP 100 million) world-leading research center for agricultural bioscience at its existing R ...